Ranbaxy spinout gets $6.5M for N.J.-based generics biz
Bionpharma just raised $6.5 million, according to a regulatory filing - on top of about $31 million raised last year.
Bion Pharma, the startup launched by ex-Ranbaxy execs, raises $21M
Bion Pharma, the New Jersey startup freshly launched by a cadre of former execs from Indian generic drugmaker Ranbaxy, has raised $21 million from two investors, according to a regulatory filing. The company’s aiming to raise $30 million. Five execs at the U.S. branch of Ranbaxy quit last month, and aim through this Princeton-based startup to […]
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.